Daniel Davis

Sequre Dx, Inc. is a genomics intelligence company that focuses on advancing on-target gene editing and cell therapies from discovery to patient. The company is based in Waltham, MA. The company offers preclinical platforms for the biopharma industry, including diagnostic assays and bioinformatic analytics that solve preclinical off-target evaluation needs. Sequre Dx aims to make gene editing and cell therapies suitable for all patients who would benefit from these life-saving technologies. The CEO of the company is Ellen E. Sheets.

Bourdon Associates, Inc. performs financial and accounting services. The firm specializes in accounting and finance consulting, part time finance staff, outsourced controllers and senior accountants, interim staffing for senior finance roles, nonprofit and endowment accounting, audit preparation, and financial systems implementation. The company was founded by Jim Bourdon in 1998 and is headquartered in Waltham, MA.

Biopure Corp. developed, manufactured and marketed oxygen therapeutics, a new class of pharmaceuticals that are administered intravenously to increase oxygen transport to the body's tissues. The company used patented and proprietary technology to develop and manufacture two products: Hemopure for human use, and Oxyglobin for veterinary use. It has developed Hemopure for the treatment of patients with cardiovascular ischemia. Oxyglobin, its veterinary product treated anemia in dogs, is the only oxygen therapeutic approved by the U.S. Food and Drug Administration and the European Commission. Biopure was founded in 1984 and was headquartered in Cambridge, MA.

Change Dynamics LLC designs and develops software solutions. The company was founded in August 2004 and is headquartered in Cedar Knolls, NJ.